CSF2 and neoplasm: T-VEC is constituted by a genetically modified herpes simplex virus type I (HSV-1) that selectively replicates in tumor cells and transfects them with a granulocyte–macrophage colony-stimulating factor (GM-CSF) encoding plasmid, resulting in increased concentrations of GM-CSF in the TME.